US equities
|
MU
$914.50
▲+0.04%
NVDA
$218.13
▼-1.43%
SNDK
$1,354.35
▼-3.49%
SPCX
$146.79
▼-3.53%
AMD
$554.39
▼-2.88%
INTC
$94.37
▼-3.82%
AAPL
$343.76
▲+0.23%
TSM
$420.56
▼-2.20%
MU
$914.50
▲+0.04%
NVDA
$218.13
▼-1.43%
SNDK
$1,354.35
▼-3.49%
SPCX
$146.79
▼-3.53%
AMD
$554.39
▼-2.88%
INTC
$94.37
▼-3.82%
AAPL
$343.76
▲+0.23%
TSM
$420.56
▼-2.20%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Justin Hanka
Recent news which mentions Justin Hanka
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
Markets
Psychedelics
Market News
From
Benzinga
MindBio Begins Recruitment Of Participants For LSD-Microdosing Clinical Trial In Cancer Patients Experiencing Emotional Distress
July 25, 2023
Tags
premium
Justin Hanka
Market News
From
Benzinga
MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants
July 19, 2023
Tags
premium
Justin Hanka
Market News
From
Benzinga